Using an epigenetic mechanism, romidepsin restored gene expression and alleviated social deficits in animal model of autism
Of all the challenges that come with a diagnosis of autism spectrum disorder (ASD), the social difficulties are among the most devastating. Currently, there is no treatment for this primary symptom of ASD. New research at the University at Buffalo reveals the first evidence that it may be possible to use a single compound to alleviate the behavioral symptoms by targeting sets of genes involved in the disease.
The research, published today in Nature Neuroscience, demonstrated that brief treatment with a very low dose of romidepsin, a Food and Drug Administration-approved anti-cancer drug, restored social deficits in animal models of autism in a sustained fashion.
The three-day treatment reversed social deficits in mice deficient in a gene called Shank 3, an important risk factor for ASD. This effect lasted for three weeks, spanning the juvenile to late adolescent period, a critical developmental stage for social and communication skills. That is equivalent to several years in humans, suggesting the effects of a similar treatment could potentially be long-lasting, the researchers say.
Profound, prolonged effect
“We have discovered a small molecule compound that shows a profound and prolonged effect on autism-like social deficits without obvious side effects, while many currently used compounds for treating a variety of psychiatric diseases have failed to exhibit the therapeutic efficacy for this core symptom of autism,” said Zhen Yan, PhD, professor in the Department of Physiology and Biophysics in the Jacobs School of Medicine and Biomedical Sciences at UB, and senior author on the paper.
The study builds on her previous research from 2015. That work revealed how the loss of Shank 3 disrupts neuronal communications by affecting the function of the NMDA (n-methyl-D-aspartate) receptor, a critical player in regulating cognition and emotion, leading to deficits in social preference that are common in ASD.
In the new research, the UB scientists found they could reverse those social deficits with a very low dose of romidepsin, which, they found, restores gene expression and function using an epigenetic mechanism, where gene changes are caused by influences other than DNA sequences. Yan noted that human genetics studies have suggested that epigenetic abnormalities likely play a major role in ASD.
To pursue these promising findings, Yan has founded a startup company called ASDDR, which was awarded a Small Business Technology Transfer grant from the National Institutes of Health last summer for more than $770,000.
Epigenetics in ASD
Many of the mutations in ASD, Yan explained, result from chromatin remodeling factors, which are involved in dynamically changing the structure of chromatin, the complex of genetic material in the cell nucleus that condenses into chromosomes.
“The extensive overlap in risk genes for autism and cancer, many of which are chromatin remodeling factors, supports the idea of repurposing epigenetic drugs used in cancer treatment as targeted treatments for autism,” said Yan.
She and her colleagues knew that chromatin regulators — which control how genetic material gains access to a cell’s transcriptional machinery — were key to treating the social deficits in ASD, but the challenge was to know how to affect key risk factors at once.
“Autism involves the loss of so many genes,” Yan explained. “To rescue the social deficits, a compound has to affect a number of genes that are involved in neuronal communication.”
To do so, the team turned to a type of chromatin remodeler called histone modifiers. They modify proteins called histones that help organize genetic material in the nucleus so gene expression can be regulated. Since many genes are altered in autism, the UB scientists knew a histone modifier might be effective.
Loosening up chromatin
In particular, they were interested in histone deacetylase (HDAC), a family of histone modifiers that are critically involved in the remodeling of chromatin structure and the transcriptional regulation of targeted genes.
“In the autism model, HDAC2 is abnormally high, which makes the chromatin in the nucleus very tight, preventing genetic material from accessing the transcriptional machinery it needs to be expressed,” said Yan. “Once HDAC2 is upregulated, it diminishes genes that should not be suppressed, and leads to behavioral changes, such as the autism-like social deficits.”
But the anti-cancer drug romidepsin, a highly potent HDAC inhibitor, turned down the effects of HDAC2, allowing genes involved in neuronal signaling to be expressed normally.
“The HDAC inhibitor loosens up the densely packed chromatin so that the transcriptional machinery gains access to the promoter area of the genes; thus they can be expressed,” Yan said.
The rescue effect on gene expression was widespread. When Yan and her co-authors conducted genome-wide screening at the Genomics and Bioinformatics Core at UB’s New York State Center of Excellence in Bioinformatics and Life Sciences, they found that romidepsin restored the majority of the more than 200 genes that were suppressed in the autism animal model they used.
“The advantage of being able to adjust a set of genes identified as key autism risk factors may explain the strong and long-lasting efficacy of this therapeutic agent for autism,” Yan explained. She and her colleagues will continue their focus on discovering and developing better therapeutic agents for autism.
The Latest on: Autism
via Google News
The Latest on: Autism
- Heartfelt moment between Disney princess and boy with autismon December 7, 2019 at 2:09 pm
LAKE BUENA VISTA, Fla. - Kids love the magic of Walt Disney World, but for one young boy with autism, the parks mean much more. The boy, 6-year-old Jackson Coley, was diagnosed with autism when he was ...
- Ways to make the holidays easier for kids with autismon December 7, 2019 at 1:34 pm
PHOENIX (3TV/CBS5) -- The holidays can be a stressful time for all of us. But the frenzied season can be even more difficult for families who have kids with autism. “The end of the year is an exciting ...
- Autism Service Dog Delivered by SDWR to Family Located at Travis Air Force Base, CAon December 7, 2019 at 12:04 am
Landin's parents are looking forward to having additional help with their son’s transitioning from task to task, sensory overload, smell sensitivity and an overall tool to cope with Landin's symptoms ...
- Louis Scarantino’s Practical Consulting Service for Coping with Autismon December 6, 2019 at 4:01 pm
SCRANTON, PA / ACCESSWIRE / December 5, 2019 / Earlier today, Louis Scarantino announced the launch of its new email-based consulting service for Coping with Autism, set to go live 10 December 2019.
- Videos capture heartwarming interaction between Disney princesses, boy with autismon December 6, 2019 at 8:05 am
IT WAS FOUR YEARS AGO THAT LITTLE JACKSON, OR JACK-JACK AS HE’S CALLED, STARTED GOING TO DISNEY. HIS FAMILY SAYS HE HAS AUTISM. AT FIRST, HE DIDN’T OPEN UP MUCH WHEN HE WENT TO THE PARKS BUT IT , WAS ...
- University of Maryland School of Medicine, partners launch autism centers for adultson December 6, 2019 at 6:49 am
People with autism and other neurodevelopmental disabilities often have few places to go for diagnosis and treatment when they are no longer children. The University of Maryland School of Medicine and ...
- Family of boy with autism needs your help to make sure he gets a good Christmason December 6, 2019 at 6:08 am
Family of boy with autism needs your help to make sure he gets a good Christmas Eleven-year-old Thomas was born with autism. His struggling mother cannot afford to give him and his sister a good ...
- Autism Action Partnership donates sensory kits to Omaha Fire Departmenton December 6, 2019 at 5:15 am
Omaha firefighters are now equipped with a way to better serve people with autism. The Autism Action Partnership on Thursday donated 16 sensory kits to the Omaha Fire Department. The kits — which ...
- Gene network sparks future autism treatmenton December 5, 2019 at 8:06 am
The gene, USP9X, regulates a network of genes underlying Intellectual Disability (ID) and Autism Spectrum Disorder (ASD). UQ School of Biomedical Sciences Associate Professor Michael Piper said ...
- 'An important piece of the puzzle': Scientists discover why gene mutation leads to autismon December 5, 2019 at 8:04 am
The search for the reasons behind intellectual disabilities and autism in children has just advanced by a significant step. Scientists at Northwestern University outside Chicago have discovered why ...
via Bing News